Lifecore Biomedical teams up with Indomo to advance at-home acne therapy
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
The document, published under the Accelerating Clinical Trials in the EU (ACT EU) initiative, sets out how trials should be conducted when health emergencies disrupt normal research operations
ShunzymeX leverages a proprietary protease to streamline purification
The system also introduces Imaging Scanner Interface 2 (ISI2) capability, enabling direct communication between injector and scanner to improve exam coordination and operational efficiency
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
Subscribe To Our Newsletter & Stay Updated